Activation of mitogen-activated protein kinase regulates eotaxin- induced eosinophil migration

Journal of Immunology

Volumn 163, Issue 3, 1999, Pages 1611-1618

  Boehme, Stefen A ^a   Sullivan, Sue K ^a   Crowe, Paul D ^a   Santos, Mark ^b   Conlon, Paul J ^a   Sriramarao, P ^b   Bacon, Kevin B ^a  

^a NEUROCRINE BIOSCIENCES INC   (United States)

^b La Jolla Institute for Experimental Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ACTIN; CD11B ANTIGEN; EOTAXIN; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR;

ALLERGY; ANIMAL TISSUE; ARTICLE; CHEMOTAXIS; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; EOSINOPHIL; HUMAN; HUMAN CELL; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL;

ACTINS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL MIGRATION INHIBITION; CHEMOKINES, CC; CHEMOTAXIS, LEUKOCYTE; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; ENZYME ACTIVATION; ENZYME INHIBITORS; EOSINOPHILS; FLAVONOIDS; HUMANS; IMMUNOPHENOTYPING; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; TIME FACTORS;

EID: 0033179690     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Weller, P.F. 1991. The immunobiology of eosinophils. N. Engl. J. Med. 324: 1110.
2. Wardlaw, A. J., R. Moqbel, and A. B. Kay. 1995. Eosinophils: biology and role in disease. Adv. Immunol. 60:151.
3. Kita, H., and G. J. Gleich. 1996. Chemokines active on eosinophils: potential roles in allergic inflammation. J. Exp. Med. 183:2421.
4. Sullivan, S., and D. H. Broide. 1996. Compartmentalization of eosinophil granulocyte-macrophage colony-stimulating factor expression in patients with asthma. J. Allergy Clin, Immunol. 97:966.
5. Luster, A. D., and M. E. Rothenberg. 1997. Role of the monocyte chemoattractant protein and eotaxin subfamily of chemokines in allergic inflammation. J. Leukocyte Biol. 62:620.
6. Ponath, P. D., S. Qin, D. J. Ringler, I. Clark-Lewis, J. Wang, N. Kassam, H. Smith, X. Shi, J.-A. Gonzalo, W. Newman, et al. 1996. Cloning of the human eosinophil chemoattractant, eotaxin. J. Clin. Invest. 97:604.
7. Teixeira, M. M., T. N. C. Wells, N. W. Lukacs, A. E. I. Proudfoot, S. L. Kunkel, T. J. Williams, and P. G. Hellewell. 1997. Chemokine-induced eosinophil recruitment. J. Clin. Invest. 100:1657.
8. Combadiere, C., S. Ahuja, and P. M. Murphy. 1995. Cloning and functional expression of a human eosinophil CC chemokine receptor. [Correction, (1995) J. Biol. Chem. 270:30235] J. Biol. Chem. 270:16491.
9. Ponath, P. D., S. Qin, T. W. Post, J. Wang, L. Wu, N. P. Gerard, W. Newman, C. Gerard, and C. R. Mackay. 1996. Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. J. Exp. Med. 183: 2437.
10. Daugherty, B. L., S. J. Siciliano, J. A. DeMartino, L. Malkowitz, A. Sirotina, and M. S. Springer. 1996. Cloning, expression, and characterization of the human eosinophil eotaxin receptor. J. Exp. Med. 183:2349.
11. Kitaura, M., T. Nakajima, T. Imai, S. Harada, C. Combadiere, H. L. Tiffany, P. M. Murphy, and O. Yoshie. 1996. Molecular cloning of human eotaxin, an eosinophil-selective CC, chemokine, and identification of a eosinophil eotaxin receptor, CC chemokine receptor 3. J. Biol. Chem. 271:7725.
12. Weng, Y., S. J. Siciliano, K. E. Waldburger, A. Sirotina-Meisher, M. J. Staruch, B. L. Daugherty, S. L. Gould, M. S. Springer, and J. A. DeMartino. 1998. Binding and functional properties of recombinant and endogenous CXCR3 receptors. J. Biol. Chem. 273:18288.
13. Rollins, B. J. 1997. Chemokines. Blood 90:909.
14. Baggiolini, M. 1998. Chemokines and leukocyte traffic. Nature 392:565.
15. Knall, C., S. Young, J. A. Nick, A. M. Buhl, G. S. Worthen, and G. L. Johnson. 1996. Interleukin-8 regulation of the Ras/Raf/mitogen-activated protein kinase pathway in human neutrophils. J. Biol. Chem. 271:2832.
16. Yen, H., Y. Zhang, S. Penfold, and B. J. Rollins. 1997. MCP-1-mediated chemotaxis requires activation of non-overlapping signal transduction pathways. J. Leukocyte Biol. 61:529.
17. Coffer, P. J., R. C. Schweizer, G. R. Dubois, T. Maikoe, J.-W. J. Lammers, and L. Koenderman. 1998. Analysis of signal transduction pathways in human eosinophils activated by chemoattractants and the T-helper 2-derived cytokines interleukin-4 and interleukin-5. Blood 91:2547.
18. Lindsay, M. A., E.-B. Haddad, J. Rousell, M. M. Texeira, P. G. Hellewell, P. J. Barnes, and M. A. Giembycz. 1998. Role of the mitogen-activated protein kinases during leukotriene B4-induced eosinophil activation. J. Leukocyte Biol. 64:555.
19. Ganju, R. K., S. A. Brubaker, J. Meyer, P. Dutt, Y. Yang, S. Qin, W. Newman, and J. E. Groopman. 1998. The α-chemokine, stromal cell-derived factor-1α, binds to the transmembrane G-protein-coupled CXCR-4 receptor and activates multiple signal transduction pathways. J. Biol. Chem. 273:23169.
20. Dubois, P. M., D. Palmer, M. L. Webb, J. A. Ledbetter, and R. A. Shapiro. 1996. Early signal transduction by the receptor to the chemokine monocyte chemolactic protein-1 in a murine T cell hybrid. J. Immunol. 156:1356.
21. Dairaghi, D. J., K. Franz-Bacon, E. Callas, J. Cupp, T. J. Schall, S. A. Tamraz, S. A. Boehme, N. Taylor, and K. B. Bacon. 1998. Macrophage inflammatory protein-1β induces migration and activation of human thymocytes. Blood 91: 2905.
22. Derijard, B., J. Raingeaud, T. Barrett, I.-H. Wu, J. Han, R. J. Ulevitch, and R. J. Davis. 1995. Independent human MAP kinase signal transduction pathways defined by MEK and MKK isoforms. Science 267:682.
23. Seger, R., N. G. Ahn, T. G. Boulton, G. D. Yancopoulos, N. Panayotatos, E. Radziejewska, L. Ericsson, R. L. Bratlien, M. H. Cobb, and E. G. Krebs. 1991. Microtubule-associated protein 2 kinases. ERK1 and ERK2, undergo autophosphorylation on both tyrosine and threonine residues: implications for their mechanism of activation. Proc. Natl. Acad. Scii. USA 88:7551.
24. Zheng, C.-F., and K.-L. Guan. 1993. Properties of MEKs, the kinases that phosphorylate and activate the extracellular signal-regulated kinases. J. Biol. Chem. 268:23933.
25. Alessi, D. R., A. Cuenda, P. Cohen, D. T. Dudley, and A. R. Saltiel. 1995. PD098059 is a specific inhibitor of the activation of mitogen-activated protein kinase in vitro and in vivo. J. Biol. Chem. 270:27489.
26. Malech, H. L., R. K. Root, and J. I. Gallin. 1977. Structural analysis of human neutrophil migration: centriole, microtubule, and microfilament orientation and function during chemotaxis. J. Cell Biol. 75:666.
27. Stossel, T. P. 1992. The mechanical responses of white blood cells. In Inflammation: Basic Principles and Clinical Correlates. J. I. Gallin, I. M. Goldstein, and R. Snyderman, eds. Raven Press, New York, pp. 459-476.
28. 2 integrin avidity by chemoattractants in eosinophils. Proc. Natl Acad. Sci. USA 93:10939.
29. Sheikh, S., W. B. Gratzer, J. C. Pinder, and G. B. Nash. 1997. Actin polymerisation regulates integrin-mediated adhesion as well as rigidity of neutrophils. Biochem. Biophys. Res. Commun. 238:910.
30. Pavalko, F. M., D, M. Walker, L. Graham, M. Goheen, C. M. Doerschuk, and G. S. Kansas. 1995. The cytoplasmic domain of L-selectin interacts with cytoskeletal proteins via α-actinin; receptor positioning in microvilli does not require interaction with α-actinin. J. Cell Biol. 129:1155.
31. Kansas, G. S., K. Ley, J. M. Munro, and T. F. Tedder. 1993. Regulation of leukocyte rolling and adhesion to high endothelial venules through the cytoplasmic domain of L-selectin. J. Exp. Med. 177:833.
32. Hansel, T. T., J. D. Pound, and R. A. Thompson. 1990. Isolation of eosinophils from human blood. J. Immunol. Methods 127:153.
33. Sriramarao, P., U. H. von Andrian, E. C. Butcher, M. A. Bourdon, and D. H. Broide. 1994. L-selectin and very late antigen-4 integrin promote eosinophil rolling at physiological shear rates in vivo. J. Immunol. 153:4238.
34. Bacon, K. B., R. D. Camp, F. M. Cunningham, and P. Woollard. 1988. Contrasting in vitro lymphocyte chemotactic activity of the hydroxyl enantiotners of 12-hydroxy-5,8,10,14-eicosatetraenoic acid. Br. J. Pharmacol. 95:966.
35. Sriramarao, P., C. R. Norton, P. Borgstrom, R. G. DiScipio, B. A. Wolitzky, and D. H. Broide. 1996. E-selectin preferentially supports neutrophil but not eosinophil rolling under conditions of flow in vitro and in vivo. J. Immunol. 157:4672.
36. DiScipio, R. G., P. J. Daffern, M. A. Jagels, D. H. Broide, and P. Sriramarao. 1999. A comparison of C3a and C5a-mediated stable adhesion of rolling eosinophils in postcapillary venules and transendothelial migration in vitro and in vivo. J. Immunol. 162:1127.
37. Barak, L. S., R. R. Yocum, E. A. Nothnagel, and W. W. Webb. 1980. Fluorescence staining of the actin cytoskeleton in living cells with 7-nitrobenz-2-oxa-1,3-diazole-phallacidin. Proc. Natl. Acad. Sci. USA 77:980.
38. Boehme, S. A., A. Gaur, P. D. Crowe, X.-J. Lui, S. Tamraz, T. Wong, A. Pahuja, N. Ling, W. Vale, E. B. De Souza, et al. 1997. Immunosuppressive phenotype of corticotropin-releasing factor transgenic mice is reversed by adrenalectomy. Cell. Immunol. 176:103.
39. Sriramarao, P., and D. H. Broide. 1996. Differential regulation of eosinophil adhesion under conditions of flow in vivo. Ann. NY Acad. Sci. 796:218.
40. Mathews, A. N., D. S. Friend, N. Zimmermann, M. N. Sarafi, A. D. Luster, E. Pearlman, S. E. Wert, and M. E. Rothenberg. 1998. Eotaxin is required for the baseline level of tissue eosinophils. Proc. Natl. Acad. Sci. USA 95:6273.
41. Franz-Bacon, K., D. J. Dairaghi, S. A. Boehme, S. K. Sullivan, T. J. Schall, P. J. Conlon, N. Taylor, and K. B. Bacon. 1999. Human thymocytes express CCR3 and are activated by eotaxin. Blood. 93:3233.
42. Gallin, J. I. 1993. Inflammation. In Fundamental Immunology. W. E. Paul, ed. Raven Press, New York, pp. 1015-1032.
43. Chuang, C. F., and S. Y. Ng. 1994. Functional divergence of the MAP kinase pathway: ERK1 and ERK2 activate specific transcription factors. FEBS Lett. 346:229.
44. Elsner, J., H. Petering, R. Hochstetter, D. Kimmig, T. N. C. Wells, A. Kapp, and A. E. J. Proudfoot. 1997. The CC chemokine antagonist Met-RANTES inhibits eosinophil effector functions through the chemokine receptors CCR1 and CCR3. Eur. J. Immunol. 27:2892.
45. Buhl, A. M., S. Osawa, and G. L. Johnson. 1995. Mitogen-activated protein kinase activation requires two signal inputs from the human anaphylatoxin C5a receptor. J. Biol. Chem. 270:19828.
46. Worthen, G. S., N. Avdi, A. M. Buhl, N. Suzuki, and G. L. Johnson. 1994. FMLP activates Ras and Raf in human neutrophils. J. Clin. Invest. 94:815.
47. Downey, G. P., J. R. Butler, H. Tapper, L. Fialkow, A. R. Saltiel, B. R. Rubin, and S. Grinstein. 1998. Importance of MEK in neutrophil microbicidal responsiveness. J. Immunol. 160:434.